Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for ratio... Read more
MarketWatch
MarketWatch
MarketWatch
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.